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Abstract
Exercise-induced bronchoconstriction (EIB) is described by transient narrowing of the airways
after exercise. It occurs in approximately 10% of the general population, while athletes may show
a higher prevalence, especially in cold weather and ice rink athletes. Diagnosis of EIB is often made
on the basis of self-reported symptoms without objective lung function tests, however, the
presence of EIB can not be accurately determined on the basis of symptoms and may be under-,
over-, or misdiagnosed. The goal of this review is to describe other clinical entities that mimic
asthma or EIB symptoms and can be confused with EIB.
Diagnosis of exercise-induced 
bronchoconstriction
Exercise-induced bronchoconstriction (EIB) is a common
entity and is described by the transient narrowing of the
airways during or most often after exercise [1-4]. It occurs
in 10-15% of the general population [5,6], while the prev-
alence of EIB in asthmatic patients is reported to be 80-
90% [7-9]. Athletes generally show a high prevalence of
EIB [10,11], especially in the cold weather [12-15], and ice
rink athletes demonstrate a much greater prevalence of
EIB than their non-ice rink counterparts [16-19]. In varsity
college or elite athletes, 21-50% demonstrate EIB,
depending upon the specific sport demands [11,20-23]
The diagnosis of EIB is often made on the basis of self-
reported symptoms without objective lung function tests.
However, the presence of EIB can not be accurately deter-
mined on the basis of symptoms [20,23,24]. Recent stud-
ies demonstrate a lack of sensitivity and specificity of the
symptoms-based diagnosis [23]. In one study of elite ath-
letes, 39% of athletes positive to exercise challenge
reported two or more symptoms, while 41% of those neg-
ative reported 2 or more symptoms [24]. In fact, history is
little more reliable than flipping a coin in making the
diagnosis of EIB.
Accurate diagnosis of EIB is essential. EIB is effectively pre-
vented by acute use of b2-agonists, leukotriene receptor
antagonists, sodium cromoglycate, and nedocromil
sodium and the chronic use of inhaled corticosteroids
[7,25,26]. However, these medications are often need-
lessly prescribed for patients who do not have EIB; they
are often used in combination when such patients do not
respond to first-line therapy. Because of the high b2-ago-
nist use among the elite athletes, the International Olym-
pic Committee (IOC) requires objective evidence to
demonstrate asthma or EIB as an indication for therapeu-
tic use of b2-agonists during competition [27,28].
Therefore, confirmation of the diagnosis of EIB through
standardized testing utilizing spirometry should be per-
formed. Current guidelines (ATS, ERS, IOC-MC) for a
diagnosis of EIB require a 10% or greater decrease in
forced expiratory flow in the first second of exhalation
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(FEV1) in response to exercise (Figure 1) or eucapnic vol-
untary hyperpnea (EVH).
Symptoms of EIB include dyspnea (sensation of discom-
fort when breathing), increased effort or work to breathe,
chest tightness, shortness of breath, air hunger, wheezing,
or cough [24,29]. However, other clinical entities can pro-
duce similar symptoms [30]. Dyspnea, in particular, is
associated with many disease processes [31,32]. In fact,
EIB is uncommon in subjects who complain of exercise-
induced dyspnea. In patients who presented with exercise
induced dyspnea, only 7-24% actually had EIB on cardi-
opulmonary testing [6,33]. "Wheeze" or stridor can also
be caused by airway abnormalities and may closely mimic
EIB.
The goal of this review is to describe other clinical entities
that mimic asthma or EIB symptoms and can be confused
with it. More than one condition may coexist in a given
patient.
Physiologic limitation and deconditioning
Increased ventilation is a normal physiologic response to
exercise. However, the increase in respiratory drive and
work may be interpreted as pathologic by subjects who
find that it limits their ability to perform to their expecta-
tions or results in "normal" discomfort. In a study by Abu-
hasan et al, physiologic limitation was the most common
reason for exercise-induced dyspnea in pediatric patients
who underwent cardiopulmonary exercise testing [34]. It
occurred in 52% of referrals for EIB; of those, two thirds
had normal or above normal cardiovascular conditioning.
The dyspnea is likely related to the increase in ventilation
that accompanies high intensity exercise which is neces-
sary to meet increased metabolic demands. Minute venti-
lation and respiratory drive are further increased at or
above the lactate or ventilatory threshold, the point in
incremental exercise when lactate begins to accumulate in
the serum; excess lactate buildup results in exercise-associ-
ated increases in ventilation and ultimately hypocapnia.
Subjects perceive dyspnea and shortness of breath at these
high exercise intensities as abnormal.
Deconditioned subjects have a lower lactate/ventilatory
threshold and begin to accumulate lactate and increase
minute ventilation with lesser amounts of exercise.
Deconditioning is a common etiology for exercise-
induced dyspnea [32]. In a study by Seear et al., 23% of
patients were "unfit" [6]. In Abu-Hasan's study, roughly
17% had decreased cardiovascular conditioning [34]. An
athlete who has become deconditioned during the "off
season" may interpret an increase in respiratory drive with
lesser amounts of exercise as pathologic or as "EIB" or
asthma.
Exercise rehabilitation or training can improve aerobic fit-
ness and endurance [8] and can shift the lactate/ventila-
tory threshold so more work is required before lactate
accumulates and ventilation increases. Improved aerobic
fitness through exercise training can thus decrease the
hyperpnea and dyspnea associated with exercise [35-37].
Obesity
Exercise-induced dyspnea is very common in obese
patients. In one epidemiological study, 80% of obese
middle aged subjects reported dyspnea after climbing two
flights of stairs [38]. In another study, 36.5% of obese
adults with a body mass index (BMI) greater than 31 and
28% of "overweight" adults (BMI 27-31) reported dysp-
nea when walking up hill [39]. In formal cardiopulmo-
nary exercise testing, 37% of healthy obese women had an
elevated perception of breathlessness during exercise [40].
There are several reasons why obese subjects experience
dyspnea during exercise. Obesity is associated with
impairment of pulmonary mechanics; in mild obesity,
Pre- and post-exercise spirogram demonstrating a 19% fall in  FEV1 Figure 1
Pre- and post-exercise spirogram demonstrating a 
19% fall in FEV1. A ≥ 10% fall is indicative of EIB.Allergy, Asthma & Clinical Immunology 2009, 5:7 http://www.aacijournal.com/content/5/1/7
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there is a reduced expiratory reserve volume (ERV) which
is likely due to the displacement of the diaphragm into the
chest cavity by the fat stores within the abdomen. With
increasing severity of obesity, there are decreases in total
lung capacity (TLC), functional residual capacity (FRC),
and maximal voluntary ventilation (MVV)[41-44].
Because of the lower lung volumes, there may be a
decrease in airway caliber and increase in airway resist-
ance. The chest wall and total respiratory system are less
compliant, which increases the work and energy cost of
breathing [45]. The decrease in end expiratory lung vol-
ume likely causes flow limitation during exercise.
Aerobic capacity and cardiopulmonary fitness may be
decreased in obese patients. Cardiopulmonary fitness,
reflected by maximal or peak oxygen consumption (VO2
max) is decreased when corrected for weight [46]. Obese
subjects are very likely to be deconditioned and ventila-
tory threshold may be reduced. Cardiac performance in
response to incremental work load may also be decreased
[47].
A number of studies have demonstrated that obese sub-
jects perceive a greater degree of dyspnea in response to
stimuli such as exercise, methacholine challenges or
asthma exacerbations [39,48,49]. In one study in obese
women, the degree of exercise-induced dyspnea was
directly correlated to increases in the oxygen cost of
breathing [40]. Weight loss can improve the pulmonary
mechanics and lung volumes in these patients [43,50].
Vocal cord abnormalities
Obstruction of the upper airway can cause symptoms such
as shortness of breath, increased inspiratory effort, stridor
and wheeze. In many subjects, upper airway obstruction is
dynamic and only presents during exercise.
Paradoxical vocal cord movement is the most common
cause of upper airway obstruction during exercise [51].
Typically, during inspiration, the vocal cords abduct
(open); however, in some subjects, they paradoxically
adduct (close) during inspiration or early expiration
which causes obstruction. The prevalence of vocal cord
dysfunction (VCD) has been reported to range from 5 -
15% in patients referred for exercise-induced dyspnea
[34,52,53]. However, in one study, the incidence was as
high as 27% [6].
Diagnosis may be suspected by history of inspiratory
wheeze and throat tightness. VCD has been associated
with gastroesophageal reflux [54] and "type A personali-
ties" [Weiss, unpublished observation]. Prevalence of
VCD appears to be gender related and is highest among
young females [53]. In a study of 370 (174 female, 196
male) elite athletes by Rundell and Spiering, 30% (58
female, 53 male) tested positive for EIB and 5.1% demon-
strated inspiratory stridor consistent with VCD; of those,
18 of 19 were females [53]. Ten of those demonstrating
inspiratory stridor were positive for EIB. Eight of the 9
demonstrating stridor that were negative for EIB had a
previous diagnosis of EIB and 7 of those were prescribed
albuterol by their physician, with no resolution of stridor.
The diagnosis of VCD is suggested by flow-volume loops
which may reveal variable blunting of the inspiratory
loop. In one study, 60% of VCD-positive patients devel-
oped abnormal flow-volume loops after metacholine
challenge [52]. Definitive diagnosis can be made by
fiberoptic rhinolaryngoscopy, which reveals the paradox-
ical motion of the vocal cords. The typical findings from
laryngoscopy are inspiratory vocal cord closure with pos-
terior "chinking" (a small opening at the posterior aspect
of the cords) or, less commonly, complete closure
[55,56].
VCD may respond to breathing retraining diaphragmatic
breathing - relaxation of larynx with conscious activation
of the diaphragm [57,58]. Speech pathologists are often
an invaluable resource in providing subjects with instruc-
tion on breathing training exercises.
Laryngomalacia is less common cause of exercise-induced
stridor. It primarily affects female competitive athletes
who abruptly develop stridor at near peak exercise [59]. It
is differentiated from vocal cord dysfunction by fiberoptic
rhinolaryngoscopy. It is characterized by collapse of the
arytenoid area; vocal cord motion is normal. The larynx in
females may be predisposed to collapse, because it is
shorter and narrower than in males. One reported patient
had a history of laryngomalacia as an infant [60]. Laryn-
gomalacia has been successfully treated with laser supra-
glottoplasty [61,62].
Anxiety and Hyperventilation Syndrome
Anxiety may produce a heightened sense of breathlessness
and dyspnea during exercise. Hyperventilation is a com-
mon physiologic response to both exercise and anxiety
but may be interpreted as a primary problem that could be
associated with chest tightness and shortness of breath
[63]. In severe cases, it may be associated with carpopedal
spasm, tetany and seizures [64]. In fact, in the past it was
suggested that patients with panic and anxiety disorders
actually had inherent respiratory and autonomic abnor-
malities. More recently, the entity of primary hyperventi-
lation syndrome has been deemed a "chimera" [65]; that
it is "no longer tenable." It is more likely that hyperventi-
lation is a result of the panic attacks and associated anxiety
[65-67].Allergy, Asthma & Clinical Immunology 2009, 5:7 http://www.aacijournal.com/content/5/1/7
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The emotional state of subjects may impact their percep-
tion of dyspnea. In subjects with high levels of anxiety and
multiple somatic complaints, there is an exaggerated per-
ception of the intensity of dyspnea when hyperventilation
is evoked by breathing 5% CO2 enriched air [68,69]. In
asthmatic patients stress, negative emotions and fear or
anticipation increase subjective reports of dyspnea [70-
72].
In subjects with a high level of anxiety, who have an exag-
gerated sense of dyspnea during exercise, it would be
worthwhile to perform cardiopulmonary exercise testing
and document the absence of EIB. In many cases, reassur-
ance that the response to exercise is normal may allay anx-
iety and improve symptoms. The power of positive
suggestion plays an important role in the relief of dyspnea
and pain perception by decreasing anxiety [73]. Breathing
retraining exercises may be helpful to decrease hyperven-
tilation and self-hypnosis has been effective in reducing
dyspnea in pediatric subjects [74]. In severe cases, phar-
macologic therapy for anxiety may be indicated.
Cardiac abnormalities
In previously healthy persons, cardiac abnormalities are a
rare cause of exercise-induced dyspnea. In older patients
with cardiovascular diseases, particularly congestive heart
failure, exercise performance is limited because of
decreases in cardiac and pulmonary reserve. Patients may
hyperventilate and experience dyspnea at lower work
loads because of earlier onset of metabolic acidosis,
decreased lung compliance and increased airways resist-
ance because of pulmonary edema and increased dead
space ventilation [75]. The ventilatory response to exercise
can be improved by treatment of the underlying heart fail-
ure [76].
Pulmonary vascular diseases, such as pulmonary hyper-
tension, can be associated with dyspnea, cardiac limita-
tion and abnormal ventilatory responses to exercise [77].
Pulmonary hypertension may be associated with lower
airways obstruction and increased airways hyperreactivity
[78,79]. In rare cases, it may present as refractory asthma
because of extrinsic proximal airway obstruction by
dilated pulmonary arteries [80]. Diagnosis is usually
made on the basis of cardiac echocardiography and cath-
eterization.
Hypertrophic cardiomyopathy (HCM), a feared cause of
sudden death in athletes, can be associated with exercise-
induced dyspnea and progressive heart failure [81-84]. It
would be unlikely, but not impossible for it to present as
"exercise-induced asthma." Those at highest risk of sud-
den death are subjects with a history of cardiac arrest or
ventricular tachycardia, family history of HCM-related
death, syncope, or left ventricular hypertrophy [82]. All
athletes who are screened by a pre-sports participation
physical should be asked about risk factors.
Cardiac dysrythmias are a rare cause of exercise-induced
dyspnea. Atrial fibrillation and other supraventricular
tachyarrhythmias are uncommon in elite athletes and
similar to that observed in the general population (< 1%)
[85]. Tachyarrythmias are often associated with palpita-
tions or, rarely, syncope. Abu-Hassan et al reported one
teenager who developed supraventricular tachycardia as a
cause of his exercise-induced dyspnea; of note, he did not
complain of palpitations [34]. Atrioventricular block
could potentially cause exertional dyspnea [86-88].
Patients may present with exercise intolerance and AV
block from Lyme disease [89]; we have documented one
pediatric patient with exercise intolerance attributed to a
complete AV block from Lyme disease [Weiss, unpub-
lished observation].
Vascular anomalies of the thoracic aorta such as a double
aortic arch or right aortic arch with persistent ligamentum
arteriosum or aberrant left subclavian artery have been
associated with dyspnea on exertion [90,91]. The mecha-
nisms for the symptoms include associated tracheomala-
cia and extrinsic compression of the airways which may
worsen during exercise because of aortic arch dilatation.
Surgical correction may be necessary.
Pulmonary arteriovenous malformations
Pulmonary arteriovenous malformations (AVM) can be
associated with exercise-intolerance and arterial hypox-
emia. Most pulmonary AVMs are associated with an auto-
somal dominant disorder, hereditary hemorrhagic
telangiectasia (HHT) or Osler-Weber Rendu [92]. The
incidence of HHT is estimated to be greater than one in
10,000 [93]; approximately 35% of patients with HHT
have pulmonary AVMs [94]. The complications of pulmo-
nary AVMs are related to the intrapulmonary right-to-left
shunt. Paradoxical emboli can result in cerebral abscesses,
cerebrovascular accidents and transient ischemic attacks
[93,95]. Most pulmonary AVMs are located at the lung
bases. Some patients demonstrate platypnea or improve-
ment in breathing on reclining [96]. Arterial hypoxemia
which is worse in the upright position or with exercise is
common [97]. Spirometry is usually normal, however,
diffusing lung capacity for carbon monoxide (DLCO) may
be decreased [97-100].
The gold-standards for diagnosis of AVMs are pulmonary
angiography and chest computed tomography [101,102].
Chest radiography, arterial oxygen measurements, cardi-
opulmonary exercise testing, radionuclide lung scanning,
contrast-enhanced MR angiography and transthoracic
contrast echocardiography (TTCE) have been used as
screening methods [103-108]. Transcatheter emboliza-Allergy, Asthma & Clinical Immunology 2009, 5:7 http://www.aacijournal.com/content/5/1/7
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tion is the therapy of choice and has been shown to
decrease the right to left-shunt and improve arterial
hypoxemia and exercise tolerance [97-100].
Pulmonary abnormalities
Other pulmonary abnormalities can present with exercise-
induced dyspnea. Chest wall or other musculoskeletal
abnormalities can impair pulmonary mechanics. In the
series of Abu-Hasan et al, 11% of patients had restrictive
physiology due to mild scoliosis or pectus abnormality as
the cause of their exercise-induced dyspnea [34]. Pectus
excavatum has been associated with exercise intolerance
and dyspnea; improvement after surgical correction has
been documented [109-111]. Mild scoliosis in adoles-
cents has been associated with abnormal ventilatory
response to exercise [112]. In contrast, in adults with
moderate kyphoscoliosis, dyspnea has been attributed to
deconditioning rather than disordered pulmonary
mechanics [113].
Tracheobronchomalacia, dynamic collapse of the central
airways, may produce airflow limitation during exercise
and has been associated with exercise intolerance [114].
The incidence of malacia has been estimated to be in 1:
2,100 children [115]. The symptoms overlap with those of
asthma and it is often unsuspected until documented by
bronchoscopy.
Interstitial lung disease is associated with exercise-
induced dyspnea. Mechanisms for dyspnea and exercise
limitation are expiratory flow limitation, hypoxemia and
altered pulmonary mechanics [116-118]. Diagnosis may
be made on the basis of pulmonary function tests reveal-
ing restrictive physiology, decreases in diffusing lung
capacity for carbon monoxide (DLCO), chest CT, serum
serology, bronchoscopy and/or lung biopsy.
The sequelae of moderate and severe chronic obstructive
pulmonary disease (COPD) on exercise-induced dyspnea
are well recognized. However, mild COPD can also be
associated with increased dyspnea with exertion which
reflects abnormal ventilatory mechanics including airway
obstruction, increases in end-expiratory lung volumes and
deconditioning [119-122].
Myopathy
Dyspnea can be associated with diseases of skeletal mus-
cles (myopathies) [123]. In muscular dystrophies, there is
a progressive loss of muscle fibers which results in increas-
ing muscle weakness. In disorders of muscle energy
metabolism, there is an imbalance in muscle energy pro-
duction and utilization during exercise which can result in
exertional muscle pain, cramping, weakness, or fatigue.
Mitochondrial myopathy is an often unrecognized cause
of exertional dyspnea and exercise intolerance [124,125].
Flaherty et al, described 28 patients with biopsy proven
myopathy and found that exercise dyspnea was associated
with decreased respiratory muscle function [126]. Cardi-
opulmonary exercise testing revealed mechanical ventila-
tory limitation and an exaggerated increase in respiratory
frequency and tachycardia in response to exercise. Many
patients had respiratory muscle weakness.
Summary
In summary, reported symptoms and history without
objective lung function tests are not adequate to make a
definitive diagnosis of EIB. Approximately half of those
athletes reporting symptoms of EIB have normal airway
function and about half of those who report no symptoms
will demonstrate bronchoconstriction after exercise or
other indirect challenge [20,23,24,127]. It is therefore
important to confirm a diagnosis of EIB through objective
measures of lung function using standardized procedures.
Indirect challenges such as exercise, eucapnic voluntary
hyperpnea (EVH) or inhaled powdered mannitol are
more specific to EIB than direct challenges such as hista-
mine or methacholine [128,129]. Figure 2 provides an
algorithm for differential diagnosis of EIB. Differential
diagnosis of EIB should include normal physiologic limi-
tation and deconditioning, obesity, upper airway obstruc-
tion such as vocal cord dysfunction or laryngomalacia,
anxiety-associated dyspnea and hyperventilation, exer-
cise-induced supraventricular tachycardia, as well as other
cardiac and pulmonary abnormalities.
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